By the third day, the sham group, donepezil, SFN (10), BSEP (400), and BSEP (200) exhibited escape latency times comparable to those of the normal control group, demonstrating significant improvement compared to the AD group (Fig. 7B). This evidence concerns the gene SFN and Alzheimer disease.